Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
Business
·
The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
CN
CitrixNews Staff
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Business
David Ellison names Ynon Kreiz co-CEO of Paramount and Warner Bros. Discovery
Paramount Skydance CEO David Ellison announced on Wednesday the appointment of outgoing Mattel Chief Executive Officer Y...
CitrixNews Staff
·
1 hour ago
Business
While Surging to Records, Stocks Experience Some ‘Wobbles’
Beneath the S&P 500’s 2 percent gain in the third quarter, the rise in oil prices and bond yields led some investors to ...
CitrixNews Staff
·
2 hours ago
Business
Trump Media’s Merger With Nuclear Fusion Company Moves Closer to Completion
A securities filing laid out the terms of the deal between Truth Social’s parent company and TAE Technologies, which was...
CitrixNews Staff
·
2 hours ago
Business
MGM CEO leaves door open to People Inc. bid as casino dealmaking heats up
MGM Resorts International CEO Bill Hornbuckle is leaving open the possibility that the casino operator could acquire Bar...
CitrixNews Staff
·
5 hours ago